Who
Bruce I. Sachs
Director
Company insider
Files Form 4 as: Director, Vertex Pharmaceuticals; Director and 10% owner, BigBand Networks.
In numbers
- Trades disclosed
- 254
- Buys
- 6
- Sells
- 33
- Bought
- $10.9M
- Sold
- $62.6M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Jun 2006
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $48K92.694 at $512.44 | filing |
| 27 Aug 2026filed 31 Aug 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —6,000 at $0.00 | filing |
| 27 Aug 2026filed 31 Aug 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —6,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $47K99.941 at $475.28 | filing |
| 15 Jul 2026filed 17 Jul 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $47K99.94 at $475.28 | filing |
| 1 May 2026filed 5 May 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,866 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,866 at $0.00 | filing |
| 15 Apr 2026filed 17 Apr 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $48K107.345 at $442.50 | filing |
| 15 Apr 2026filed 17 Apr 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $48K107.35 at $442.50 | filing |
| 15 Jan 2026filed 20 Jan 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $47K107.088 at $443.56 | filing |
| 15 Jan 2026filed 20 Jan 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $48K107.09 at $443.56 | filing |
| 15 Oct 2025filed 17 Oct 2025 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $48K115.77 at $410.31 | filing |
| 6 Aug 2025filed 7 Aug 2025 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $636K1,634 at $389.36 | filing |
| 6 Aug 2025filed 7 Aug 2025 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $1.3M3,366 at $389.84 | filing |
| 15 Jul 2025filed 17 Jul 2025 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $48K101.21 at $469.34 | filing |
| 1 May 2025filed 5 May 2025 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,398 at $0.00 | filing |
| 15 Apr 2025filed 17 Apr 2025 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $48K95.48 at $497.51 | filing |
| 15 Jan 2025filed 17 Jan 2025 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $47K111.65 at $420.31 | filing |
| 15 Oct 2024filed 17 Oct 2024 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $44K90.32 at $484.39 | filing |
| 1 Aug 2024filed 2 Aug 2024 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,295 at $0.00 | filing |
News
Head to Head Analysis: Caribou Biosciences (NASDAQ:CRBU) & Vertex Pharmaceuticals (NASDAQ:VRTX)VRTX · tickerreport.com · 14 Oct 2026Vertex Pharmaceuticals Incorporated: Vertex to Present New Data on ALYFTREK at the North American Cystic Fibrosis ConferenceVRTX · finanznachrichten.de · 9 Oct 2026
0 headlines in the last 90 days name Bruce I. Sachs; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.